|
Volumn 19, Issue 4, 2013, Pages 688-
|
Hepatitis E virus and porcine-derived Heparin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
BILIRUBIN;
CLEXHANE;
DALTEPARIN;
ENOXAPARIN;
HEPARIN;
LEPIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
UNCLASSIFIED DRUG;
PORCINE;
ADULT;
CASE REPORT;
DISEASE TRANSMISSION;
FEMALE;
GENE SEQUENCE;
GENOTYPE;
HEPATITIS;
HEPATITIS E VIRUS;
HUMAN;
IATROGENIC DISEASE;
LETTER;
LIMIT OF DETECTION;
LIVER FUNCTION TEST;
PORCINE PARVOVIRUS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RISK FACTOR;
THROMBOEMBOLISM;
VIRAL CONTAMINATION;
ANIMAL;
DRUG SURVEILLANCE PROGRAM;
ENZYMOLOGY;
HEPATITIS E;
HEV;
ISOLATION AND PURIFICATION;
METABOLISM;
PATHOPHYSIOLOGY;
PORCINE CIRCOVIRUS 2;
SWINE;
VIRUS;
ZOONOSIS;
HEPARIN;
HEPATITIS E;
HEV;
PHARMACOVIGILANCE;
PORCINE;
PORCINE CIRCOVIRUS 2;
PORCINE PARVOVIRUS;
VIRUSES;
ZOONOSES;
ADULT;
ANIMALS;
FEMALE;
HEPARIN;
HEPATITIS E;
HEPATITIS E VIRUS;
HUMANS;
LIVER FUNCTION TESTS;
SWINE;
|
EID: 84875331376
PISSN: 10806040
EISSN: 10806059
Source Type: Journal
DOI: 10.3201/eid1904.121792 Document Type: Letter |
Times cited : (10)
|
References (10)
|